GlassScriptPhysician profile
Staci L Mchale
NPI 1033328323
$17,402.01
in general payments reported to CMS, 2019-2025
38 companies · $2,306 in 2025
The $2,306 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $321 · 2021: $360 · 2022: $921 · 2023: $13K · 2024: $387 · 2025: $2,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Food and Beverage: $2,223 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600 · Travel and Lodging: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,675.94 |
| Food and Beverage | $2,222.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
| Travel and Lodging | $750.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,748.91 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Bayer Healthcare Pharmaceuticals INC. | $1,717.45 | 2019-2025 | |
| Abbvie INC. | $842.22 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $477.81 | 2022-2025 | |
| Astellas Pharma US INC | $367.08 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $295.17 | 2023-2025 | Aptima, Acessa Provu System, Thinprep 2000 Processor |
| Exeltis, USA INC. | $241.45 | 2020-2023 | Slynd |
| Therapeuticsmd, INC. | $199.75 | 2019-2022 | |
| Pfizer INC. | $161.37 | 2021-2023 | |
| Gynesonics, INC. | $145.44 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lupin INC. | $131.14 | 2019 | |
| Amag Pharmaceuticals, INC. | $115.20 | 2019 | |
| Sumitomo Pharma America, INC. | $111.52 | 2023-2025 | Myfembree |
| Organon LLC | $102.44 | 2021-2024 | Nexplanon |
| Ethicon US, LLC | $75.22 | 2024 | Harmonic, Vistaseal, Stratafix |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $52.98 | 2019-2021 | |
| Sage Therapeutics, LLC | $51.94 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $50.74 | 2021-2022 | |
| Exact Sciences Corporation | $49.17 | 2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $47.84 | 2019-2024 | Injectafer |
| Shield Therapeutics INC | $39.97 | 2023 | Accrufer |
| Medicem INC. | $37.19 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.98 | 2022 | |
| Allergan, INC. | $31.77 | 2019-2020 | |
| Avion Pharmaceuticals | $31.02 | 2021-2023 | Balcoltra |
| Pacira Pharmaceuticals Incorporated | $28.88 | 2022 | |
| Conmed Corporation | $26.79 | 2023 | Airseal, Conmed Specimen Retrieval |
| Duchesnay USA Incorporated | $24.99 | 2019 | |
| Covidien LP | $22.89 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $21.70 | 2020 | |
| Integra Lifesciences Corporation | $19.91 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Supernus Pharmaceuticals, INC. | $15.13 | 2025 | Qelbree |
| Minerva Surgical, INC | $14.80 | 2025 | |
| Becton, Dickinson and Company | $14.67 | 2024 | Bd Onclarity |
| Agile Therapeutics, INC. | $14.57 | 2022 | |
| Coopersurgical, INC. | $13.55 | 2025 | Ally II Ups |
| Mylan Pharmaceuticals INC. | $12.65 | 2021 | |
| Zyla Life Sciences, INC. | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Staci Mchale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.